PROVIDENCE – CVS Health Corp. has agreed to pay $37.76 million to settle claims it improperly overdispensed and overbilled federal health care programs for insulin pens between 2010 and 2020, according to a report by Reuters. The settlement, announced by U.S. Attorney Jay Clayton in Manhattan on Dec. 2, resolves the accusation by the U.S. Already a Subscriber? Log in

To Continue Reading This Article Become a Providence Business News subscriber and get immediate access to all of our premier content and much more.

Learn More and Become a Subscriber

Critical RI business news and analysis updated daily.

1 year of print (26 issues).

Unlimited access to all subscriber only content on our website, on any device.

Free email alerts.

Annual Book of Lists Print Edition.

All special issues p

See Full Page